Showing 1 - 7 results of 7 for search 'PHARMACEUTICAL INDUSTRY PRACTICE', query time: 1.16s Refine Results
  1. 1
    Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice
    “... funds, the Belgian reimbursement agency, pharmaceutical industry and patient organizations. Interviews...”
    Get full text
    Article
  2. 2
    On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
    “... costs while the return-on-investment for the pharmaceutical industry is expected to be low or absent...”
    Get full text
    Article
  3. 3
    Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review
    “...) bodies, reimbursement agencies, industry, patients, physicians and regulators. This review aimed...”
    Get full text
    Article
  4. 4
    Personalized and long-term electronic informed consent in clinical research: stakeholder views
    “... representatives, ethics committee members, and pharmaceutical industry representatives, and all were involved...”
    Get full text
    Article
  5. 5
    Taking Bacteriophage Therapy Seriously: A Moral Argument
    “... of the pharmaceutical industry. Early in the 20th century, bacteriophages were described as entities that can control...”
    Get full text
    Article
  6. 6
    Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
    “... clinical practice. This gap could potentially be bridged by transitioning toward a patient-centered...”
    Get full text
    Article
  7. 7
    Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US
    “...Objectives: Patient preference information (PPI) is gaining recognition among the pharmaceutical...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search